Global Bioequivalent Peptide Drugs Supply, Demand and Key Producers, 2023-2029

September 2023 | 107 pages | ID: GA71DB950EA3EN
GlobalInfoResearch

Abstracts

The global Bioequivalent Peptide Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The development and production of bioequivalent peptide drugs usually requires detailed comparison and analysis, including in vitro and in vivo experimental evaluation, and comparison of clinical trial data. Bioequivalent peptide drugs have a wide range of applications in drug replacement, therapeutic expansion, and biosimilars.

A bioequivalent peptide drug is one that has similar structure and function, and exhibits similar pharmacokinetic and pharmacodynamic properties in vivo to the original brand drug or an approved reference product. These drugs are usually synthesized through genetic recombination technology and undergo rigorous research and development and approval procedures.

This report studies the global Bioequivalent Peptide Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Bioequivalent Peptide Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bioequivalent Peptide Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Bioequivalent Peptide Drugs total production and demand, 2018-2029, (Units)

Global Bioequivalent Peptide Drugs total production value, 2018-2029, (USD Million)

Global Bioequivalent Peptide Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)

Global Bioequivalent Peptide Drugs consumption by region & country, CAGR, 2018-2029 & (Units)

U.S. VS China: Bioequivalent Peptide Drugs domestic production, consumption, key domestic manufacturers and share

Global Bioequivalent Peptide Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)

Global Bioequivalent Peptide Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)

Global Bioequivalent Peptide Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units).

This reports profiles key players in the global Bioequivalent Peptide Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly and Company, Alvogen, Pfenex, HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Ambio Pharmaceuticals and Jiangsu Sinopep Allsino Biopharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bioequivalent Peptide Drugs market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Bioequivalent Peptide Drugs Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Bioequivalent Peptide Drugs Market, Segmentation by Type

• Teriparatide(Forteo)
• Teduglutide(Gattex)
• Liraglutide(Victoza)

Global Bioequivalent Peptide Drugs Market, Segmentation by Application

• Short Bowel Syndrome
• Osteoporosis
• Type 2 Diabetes
• Others

Companies Profiled:

• Eli Lilly and Company
• Alvogen
• Pfenex
• HEC Pharm
• Bachem
• Bharat Pharmaceuticals
• Kingpep Biotechnology
• Ambio Pharmaceuticals
• Jiangsu Sinopep Allsino Biopharmaceutical
• Shanghai Shyndec Pharmaceutical
• Shenzhen Salubris Pharmaceuticals
• Shanghai United Cell Biotechnology
• Shenzhen JYMed Technology
• Wuxi Asiapeptide Biotechnology

Key Questions Answered

1. How big is the global Bioequivalent Peptide Drugs market?

2. What is the demand of the global Bioequivalent Peptide Drugs market?

3. What is the year over year growth of the global Bioequivalent Peptide Drugs market?

4. What is the production and production value of the global Bioequivalent Peptide Drugs market?

5. Who are the key producers in the global Bioequivalent Peptide Drugs market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Bioequivalent Peptide Drugs Introduction
1.2 World Bioequivalent Peptide Drugs Supply & Forecast
  1.2.1 World Bioequivalent Peptide Drugs Production Value (2018 & 2022 & 2029)
  1.2.2 World Bioequivalent Peptide Drugs Production (2018-2029)
  1.2.3 World Bioequivalent Peptide Drugs Pricing Trends (2018-2029)
1.3 World Bioequivalent Peptide Drugs Production by Region (Based on Production Site)
  1.3.1 World Bioequivalent Peptide Drugs Production Value by Region (2018-2029)
  1.3.2 World Bioequivalent Peptide Drugs Production by Region (2018-2029)
  1.3.3 World Bioequivalent Peptide Drugs Average Price by Region (2018-2029)
  1.3.4 North America Bioequivalent Peptide Drugs Production (2018-2029)
  1.3.5 Europe Bioequivalent Peptide Drugs Production (2018-2029)
  1.3.6 China Bioequivalent Peptide Drugs Production (2018-2029)
  1.3.7 Japan Bioequivalent Peptide Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Bioequivalent Peptide Drugs Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Bioequivalent Peptide Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Bioequivalent Peptide Drugs Demand (2018-2029)
2.2 World Bioequivalent Peptide Drugs Consumption by Region
  2.2.1 World Bioequivalent Peptide Drugs Consumption by Region (2018-2023)
  2.2.2 World Bioequivalent Peptide Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Bioequivalent Peptide Drugs Consumption (2018-2029)
2.4 China Bioequivalent Peptide Drugs Consumption (2018-2029)
2.5 Europe Bioequivalent Peptide Drugs Consumption (2018-2029)
2.6 Japan Bioequivalent Peptide Drugs Consumption (2018-2029)
2.7 South Korea Bioequivalent Peptide Drugs Consumption (2018-2029)
2.8 ASEAN Bioequivalent Peptide Drugs Consumption (2018-2029)
2.9 India Bioequivalent Peptide Drugs Consumption (2018-2029)

3 WORLD BIOEQUIVALENT PEPTIDE DRUGS MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Bioequivalent Peptide Drugs Production Value by Manufacturer (2018-2023)
3.2 World Bioequivalent Peptide Drugs Production by Manufacturer (2018-2023)
3.3 World Bioequivalent Peptide Drugs Average Price by Manufacturer (2018-2023)
3.4 Bioequivalent Peptide Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Bioequivalent Peptide Drugs Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Bioequivalent Peptide Drugs in 2022
  3.5.3 Global Concentration Ratios (CR8) for Bioequivalent Peptide Drugs in 2022
3.6 Bioequivalent Peptide Drugs Market: Overall Company Footprint Analysis
  3.6.1 Bioequivalent Peptide Drugs Market: Region Footprint
  3.6.2 Bioequivalent Peptide Drugs Market: Company Product Type Footprint
  3.6.3 Bioequivalent Peptide Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Bioequivalent Peptide Drugs Production Value Comparison
  4.1.1 United States VS China: Bioequivalent Peptide Drugs Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Bioequivalent Peptide Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Bioequivalent Peptide Drugs Production Comparison
  4.2.1 United States VS China: Bioequivalent Peptide Drugs Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Bioequivalent Peptide Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Bioequivalent Peptide Drugs Consumption Comparison
  4.3.1 United States VS China: Bioequivalent Peptide Drugs Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Bioequivalent Peptide Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Bioequivalent Peptide Drugs Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Bioequivalent Peptide Drugs Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Bioequivalent Peptide Drugs Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Bioequivalent Peptide Drugs Production (2018-2023)
4.5 China Based Bioequivalent Peptide Drugs Manufacturers and Market Share
  4.5.1 China Based Bioequivalent Peptide Drugs Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Bioequivalent Peptide Drugs Production Value (2018-2023)
  4.5.3 China Based Manufacturers Bioequivalent Peptide Drugs Production (2018-2023)
4.6 Rest of World Based Bioequivalent Peptide Drugs Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Bioequivalent Peptide Drugs Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Bioequivalent Peptide Drugs Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Bioequivalent Peptide Drugs Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Bioequivalent Peptide Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Teriparatide(Forteo)
  5.2.2 Teduglutide(Gattex)
  5.2.3 Liraglutide(Victoza)
5.3 Market Segment by Type
  5.3.1 World Bioequivalent Peptide Drugs Production by Type (2018-2029)
  5.3.2 World Bioequivalent Peptide Drugs Production Value by Type (2018-2029)
  5.3.3 World Bioequivalent Peptide Drugs Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Bioequivalent Peptide Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Short Bowel Syndrome
  6.2.2 Osteoporosis
  6.2.3 Type 2 Diabetes
  6.2.4 Others
6.3 Market Segment by Application
  6.3.1 World Bioequivalent Peptide Drugs Production by Application (2018-2029)
  6.3.2 World Bioequivalent Peptide Drugs Production Value by Application (2018-2029)
  6.3.3 World Bioequivalent Peptide Drugs Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Eli Lilly and Company
  7.1.1 Eli Lilly and Company Details
  7.1.2 Eli Lilly and Company Major Business
  7.1.3 Eli Lilly and Company Bioequivalent Peptide Drugs Product and Services
  7.1.4 Eli Lilly and Company Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Eli Lilly and Company Recent Developments/Updates
  7.1.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.2 Alvogen
  7.2.1 Alvogen Details
  7.2.2 Alvogen Major Business
  7.2.3 Alvogen Bioequivalent Peptide Drugs Product and Services
  7.2.4 Alvogen Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Alvogen Recent Developments/Updates
  7.2.6 Alvogen Competitive Strengths & Weaknesses
7.3 Pfenex
  7.3.1 Pfenex Details
  7.3.2 Pfenex Major Business
  7.3.3 Pfenex Bioequivalent Peptide Drugs Product and Services
  7.3.4 Pfenex Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Pfenex Recent Developments/Updates
  7.3.6 Pfenex Competitive Strengths & Weaknesses
7.4 HEC Pharm
  7.4.1 HEC Pharm Details
  7.4.2 HEC Pharm Major Business
  7.4.3 HEC Pharm Bioequivalent Peptide Drugs Product and Services
  7.4.4 HEC Pharm Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 HEC Pharm Recent Developments/Updates
  7.4.6 HEC Pharm Competitive Strengths & Weaknesses
7.5 Bachem
  7.5.1 Bachem Details
  7.5.2 Bachem Major Business
  7.5.3 Bachem Bioequivalent Peptide Drugs Product and Services
  7.5.4 Bachem Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Bachem Recent Developments/Updates
  7.5.6 Bachem Competitive Strengths & Weaknesses
7.6 Bharat Pharmaceuticals
  7.6.1 Bharat Pharmaceuticals Details
  7.6.2 Bharat Pharmaceuticals Major Business
  7.6.3 Bharat Pharmaceuticals Bioequivalent Peptide Drugs Product and Services
  7.6.4 Bharat Pharmaceuticals Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Bharat Pharmaceuticals Recent Developments/Updates
  7.6.6 Bharat Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Kingpep Biotechnology
  7.7.1 Kingpep Biotechnology Details
  7.7.2 Kingpep Biotechnology Major Business
  7.7.3 Kingpep Biotechnology Bioequivalent Peptide Drugs Product and Services
  7.7.4 Kingpep Biotechnology Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Kingpep Biotechnology Recent Developments/Updates
  7.7.6 Kingpep Biotechnology Competitive Strengths & Weaknesses
7.8 Ambio Pharmaceuticals
  7.8.1 Ambio Pharmaceuticals Details
  7.8.2 Ambio Pharmaceuticals Major Business
  7.8.3 Ambio Pharmaceuticals Bioequivalent Peptide Drugs Product and Services
  7.8.4 Ambio Pharmaceuticals Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Ambio Pharmaceuticals Recent Developments/Updates
  7.8.6 Ambio Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Jiangsu Sinopep Allsino Biopharmaceutical
  7.9.1 Jiangsu Sinopep Allsino Biopharmaceutical Details
  7.9.2 Jiangsu Sinopep Allsino Biopharmaceutical Major Business
  7.9.3 Jiangsu Sinopep Allsino Biopharmaceutical Bioequivalent Peptide Drugs Product and Services
  7.9.4 Jiangsu Sinopep Allsino Biopharmaceutical Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Jiangsu Sinopep Allsino Biopharmaceutical Recent Developments/Updates
  7.9.6 Jiangsu Sinopep Allsino Biopharmaceutical Competitive Strengths & Weaknesses
7.10 Shanghai Shyndec Pharmaceutical
  7.10.1 Shanghai Shyndec Pharmaceutical Details
  7.10.2 Shanghai Shyndec Pharmaceutical Major Business
  7.10.3 Shanghai Shyndec Pharmaceutical Bioequivalent Peptide Drugs Product and Services
  7.10.4 Shanghai Shyndec Pharmaceutical Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
  7.10.6 Shanghai Shyndec Pharmaceutical Competitive Strengths & Weaknesses
7.11 Shenzhen Salubris Pharmaceuticals
  7.11.1 Shenzhen Salubris Pharmaceuticals Details
  7.11.2 Shenzhen Salubris Pharmaceuticals Major Business
  7.11.3 Shenzhen Salubris Pharmaceuticals Bioequivalent Peptide Drugs Product and Services
  7.11.4 Shenzhen Salubris Pharmaceuticals Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
  7.11.6 Shenzhen Salubris Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Shanghai United Cell Biotechnology
  7.12.1 Shanghai United Cell Biotechnology Details
  7.12.2 Shanghai United Cell Biotechnology Major Business
  7.12.3 Shanghai United Cell Biotechnology Bioequivalent Peptide Drugs Product and Services
  7.12.4 Shanghai United Cell Biotechnology Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.12.5 Shanghai United Cell Biotechnology Recent Developments/Updates
  7.12.6 Shanghai United Cell Biotechnology Competitive Strengths & Weaknesses
7.13 Shenzhen JYMed Technology
  7.13.1 Shenzhen JYMed Technology Details
  7.13.2 Shenzhen JYMed Technology Major Business
  7.13.3 Shenzhen JYMed Technology Bioequivalent Peptide Drugs Product and Services
  7.13.4 Shenzhen JYMed Technology Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.13.5 Shenzhen JYMed Technology Recent Developments/Updates
  7.13.6 Shenzhen JYMed Technology Competitive Strengths & Weaknesses
7.14 Wuxi Asiapeptide Biotechnology
  7.14.1 Wuxi Asiapeptide Biotechnology Details
  7.14.2 Wuxi Asiapeptide Biotechnology Major Business
  7.14.3 Wuxi Asiapeptide Biotechnology Bioequivalent Peptide Drugs Product and Services
  7.14.4 Wuxi Asiapeptide Biotechnology Bioequivalent Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.14.5 Wuxi Asiapeptide Biotechnology Recent Developments/Updates
  7.14.6 Wuxi Asiapeptide Biotechnology Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Bioequivalent Peptide Drugs Industry Chain
8.2 Bioequivalent Peptide Drugs Upstream Analysis
  8.2.1 Bioequivalent Peptide Drugs Core Raw Materials
  8.2.2 Main Manufacturers of Bioequivalent Peptide Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Bioequivalent Peptide Drugs Production Mode
8.6 Bioequivalent Peptide Drugs Procurement Model
8.7 Bioequivalent Peptide Drugs Industry Sales Model and Sales Channels
  8.7.1 Bioequivalent Peptide Drugs Sales Model
  8.7.2 Bioequivalent Peptide Drugs Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Bioequivalent Peptide Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Bioequivalent Peptide Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Bioequivalent Peptide Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Bioequivalent Peptide Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Bioequivalent Peptide Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Bioequivalent Peptide Drugs Production by Region (2018-2023) & (Units)
Table 7. World Bioequivalent Peptide Drugs Production by Region (2024-2029) & (Units)
Table 8. World Bioequivalent Peptide Drugs Production Market Share by Region (2018-2023)
Table 9. World Bioequivalent Peptide Drugs Production Market Share by Region (2024-2029)
Table 10. World Bioequivalent Peptide Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Bioequivalent Peptide Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Bioequivalent Peptide Drugs Major Market Trends
Table 13. World Bioequivalent Peptide Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Units)
Table 14. World Bioequivalent Peptide Drugs Consumption by Region (2018-2023) & (Units)
Table 15. World Bioequivalent Peptide Drugs Consumption Forecast by Region (2024-2029) & (Units)
Table 16. World Bioequivalent Peptide Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Bioequivalent Peptide Drugs Producers in 2022
Table 18. World Bioequivalent Peptide Drugs Production by Manufacturer (2018-2023) & (Units)
Table 19. Production Market Share of Key Bioequivalent Peptide Drugs Producers in 2022
Table 20. World Bioequivalent Peptide Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Bioequivalent Peptide Drugs Company Evaluation Quadrant
Table 22. World Bioequivalent Peptide Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Bioequivalent Peptide Drugs Production Site of Key Manufacturer
Table 24. Bioequivalent Peptide Drugs Market: Company Product Type Footprint
Table 25. Bioequivalent Peptide Drugs Market: Company Product Application Footprint
Table 26. Bioequivalent Peptide Drugs Competitive Factors
Table 27. Bioequivalent Peptide Drugs New Entrant and Capacity Expansion Plans
Table 28. Bioequivalent Peptide Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Bioequivalent Peptide Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Bioequivalent Peptide Drugs Production Comparison, (2018 & 2022 & 2029) & (Units)
Table 31. United States VS China Bioequivalent Peptide Drugs Consumption Comparison, (2018 & 2022 & 2029) & (Units)
Table 32. United States Based Bioequivalent Peptide Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Bioequivalent Peptide Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Bioequivalent Peptide Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Bioequivalent Peptide Drugs Production (2018-2023) & (Units)
Table 36. United States Based Manufacturers Bioequivalent Peptide Drugs Production Market Share (2018-2023)
Table 37. China Based Bioequivalent Peptide Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Bioequivalent Peptide Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Bioequivalent Peptide Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Bioequivalent Peptide Drugs Production (2018-2023) & (Units)
Table 41. China Based Manufacturers Bioequivalent Peptide Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Bioequivalent Peptide Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Bioequivalent Peptide Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Bioequivalent Peptide Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Bioequivalent Peptide Drugs Production (2018-2023) & (Units)
Table 46. Rest of World Based Manufacturers Bioequivalent Peptide Drugs Production Market Share (2018-2023)
Table 47. World Bioequivalent Peptide Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Bioequivalent Peptide Drugs Production by Type (2018-2023) & (Units)
Table 49. World Bioequivalent Peptide Drugs Production by Type (2024-2029) & (Units)
Table 50. World Bioequivalent Peptide Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Bioequivalent Peptide Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Bioequivalent Peptide Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Bioequivalent Peptide Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Bioequivalent Peptide Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Bioequivalent Peptide Drugs Production by Application (2018-2023) & (Units)
Table 56. World Bioequivalent Peptide Drugs Production by Application (2024-2029) & (Units)
Table 57. World Bioequivalent Peptide Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Bioequivalent Peptide Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Bioequivalent Peptide Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Bioequivalent Peptide Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 62. Eli Lilly and Company Major Business
Table 63. Eli Lilly and Company Bioequivalent Peptide Drugs Product and Services
Table 64. Eli Lilly and Company Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Eli Lilly and Company Recent Developments/Updates
Table 66. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 67. Alvogen Basic Information, Manufacturing Base and Competitors
Table 68. Alvogen Major Business
Table 69. Alvogen Bioequivalent Peptide Drugs Product and Services
Table 70. Alvogen Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Alvogen Recent Developments/Updates
Table 72. Alvogen Competitive Strengths & Weaknesses
Table 73. Pfenex Basic Information, Manufacturing Base and Competitors
Table 74. Pfenex Major Business
Table 75. Pfenex Bioequivalent Peptide Drugs Product and Services
Table 76. Pfenex Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfenex Recent Developments/Updates
Table 78. Pfenex Competitive Strengths & Weaknesses
Table 79. HEC Pharm Basic Information, Manufacturing Base and Competitors
Table 80. HEC Pharm Major Business
Table 81. HEC Pharm Bioequivalent Peptide Drugs Product and Services
Table 82. HEC Pharm Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. HEC Pharm Recent Developments/Updates
Table 84. HEC Pharm Competitive Strengths & Weaknesses
Table 85. Bachem Basic Information, Manufacturing Base and Competitors
Table 86. Bachem Major Business
Table 87. Bachem Bioequivalent Peptide Drugs Product and Services
Table 88. Bachem Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Bachem Recent Developments/Updates
Table 90. Bachem Competitive Strengths & Weaknesses
Table 91. Bharat Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Bharat Pharmaceuticals Major Business
Table 93. Bharat Pharmaceuticals Bioequivalent Peptide Drugs Product and Services
Table 94. Bharat Pharmaceuticals Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bharat Pharmaceuticals Recent Developments/Updates
Table 96. Bharat Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Kingpep Biotechnology Basic Information, Manufacturing Base and Competitors
Table 98. Kingpep Biotechnology Major Business
Table 99. Kingpep Biotechnology Bioequivalent Peptide Drugs Product and Services
Table 100. Kingpep Biotechnology Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Kingpep Biotechnology Recent Developments/Updates
Table 102. Kingpep Biotechnology Competitive Strengths & Weaknesses
Table 103. Ambio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Ambio Pharmaceuticals Major Business
Table 105. Ambio Pharmaceuticals Bioequivalent Peptide Drugs Product and Services
Table 106. Ambio Pharmaceuticals Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Ambio Pharmaceuticals Recent Developments/Updates
Table 108. Ambio Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Jiangsu Sinopep Allsino Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Jiangsu Sinopep Allsino Biopharmaceutical Major Business
Table 111. Jiangsu Sinopep Allsino Biopharmaceutical Bioequivalent Peptide Drugs Product and Services
Table 112. Jiangsu Sinopep Allsino Biopharmaceutical Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Jiangsu Sinopep Allsino Biopharmaceutical Recent Developments/Updates
Table 114. Jiangsu Sinopep Allsino Biopharmaceutical Competitive Strengths & Weaknesses
Table 115. Shanghai Shyndec Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Shanghai Shyndec Pharmaceutical Major Business
Table 117. Shanghai Shyndec Pharmaceutical Bioequivalent Peptide Drugs Product and Services
Table 118. Shanghai Shyndec Pharmaceutical Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 120. Shanghai Shyndec Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Shenzhen Salubris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Shenzhen Salubris Pharmaceuticals Major Business
Table 123. Shenzhen Salubris Pharmaceuticals Bioequivalent Peptide Drugs Product and Services
Table 124. Shenzhen Salubris Pharmaceuticals Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
Table 126. Shenzhen Salubris Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. Shanghai United Cell Biotechnology Basic Information, Manufacturing Base and Competitors
Table 128. Shanghai United Cell Biotechnology Major Business
Table 129. Shanghai United Cell Biotechnology Bioequivalent Peptide Drugs Product and Services
Table 130. Shanghai United Cell Biotechnology Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 132. Shanghai United Cell Biotechnology Competitive Strengths & Weaknesses
Table 133. Shenzhen JYMed Technology Basic Information, Manufacturing Base and Competitors
Table 134. Shenzhen JYMed Technology Major Business
Table 135. Shenzhen JYMed Technology Bioequivalent Peptide Drugs Product and Services
Table 136. Shenzhen JYMed Technology Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Shenzhen JYMed Technology Recent Developments/Updates
Table 138. Wuxi Asiapeptide Biotechnology Basic Information, Manufacturing Base and Competitors
Table 139. Wuxi Asiapeptide Biotechnology Major Business
Table 140. Wuxi Asiapeptide Biotechnology Bioequivalent Peptide Drugs Product and Services
Table 141. Wuxi Asiapeptide Biotechnology Bioequivalent Peptide Drugs Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Bioequivalent Peptide Drugs Upstream (Raw Materials)
Table 143. Bioequivalent Peptide Drugs Typical Customers
Table 144. Bioequivalent Peptide Drugs Typical Distributors
List of Figure
Figure 1. Bioequivalent Peptide Drugs Picture
Figure 2. World Bioequivalent Peptide Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Bioequivalent Peptide Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Bioequivalent Peptide Drugs Production (2018-2029) & (Units)
Figure 5. World Bioequivalent Peptide Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Bioequivalent Peptide Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Bioequivalent Peptide Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Bioequivalent Peptide Drugs Production (2018-2029) & (Units)
Figure 9. Europe Bioequivalent Peptide Drugs Production (2018-2029) & (Units)
Figure 10. China Bioequivalent Peptide Drugs Production (2018-2029) & (Units)
Figure 11. Japan Bioequivalent Peptide Drugs Production (2018-2029) & (Units)
Figure 12. Bioequivalent Peptide Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Bioequivalent Peptide Drugs Consumption (2018-2029) & (Units)
Figure 15. World Bioequivalent Peptide Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Bioequivalent Peptide Drugs Consumption (2018-2029) & (Units)
Figure 17. China Bioequivalent Peptide Drugs Consumption (2018-2029) & (Units)
Figure 18. Europe Bioequivalent Peptide Drugs Consumption (2018-2029) & (Units)
Figure 19. Japan Bioequivalent Peptide Drugs Consumption (2018-2029) & (Units)
Figure 20. South Korea Bioequivalent Peptide Drugs Consumption (2018-2029) & (Units)
Figure 21. ASEAN Bioequivalent Peptide Drugs Consumption (2018-2029) & (Units)
Figure 22. India Bioequivalent Peptide Drugs Consumption (2018-2029) & (Units)
Figure 23. Producer Shipments of Bioequivalent Peptide Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Bioequivalent Peptide Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Bioequivalent Peptide Drugs Markets in 2022
Figure 26. United States VS China: Bioequivalent Peptide Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Bioequivalent Peptide Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Bioequivalent Peptide Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Bioequivalent Peptide Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Bioequivalent Peptide Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Bioequivalent Peptide Drugs Production Market Share 2022
Figure 32. World Bioequivalent Peptide Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Bioequivalent Peptide Drugs Production Value Market Share by Type in 2022
Figure 34. Teriparatide(Forteo)
Figure 35. Teduglutide(Gattex)
Figure 36. Liraglutide(Victoza)
Figure 37. World Bioequivalent Peptide Drugs Production Market Share by Type (2018-2029)
Figure 38. World Bioequivalent Peptide Drugs Production Value Market Share by Type (2018-2029)
Figure 39. World Bioequivalent Peptide Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Bioequivalent Peptide Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Bioequivalent Peptide Drugs Production Value Market Share by Application in 2022
Figure 42. Short Bowel Syndrome
Figure 43. Osteoporosis
Figure 44. Type 2 Diabetes
Figure 45. Others
Figure 46. World Bioequivalent Peptide Drugs Production Market Share by Application (2018-2029)
Figure 47. World Bioequivalent Peptide Drugs Production Value Market Share by Application (2018-2029)
Figure 48. World Bioequivalent Peptide Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Bioequivalent Peptide Drugs Industry Chain
Figure 50. Bioequivalent Peptide Drugs Procurement Model
Figure 51. Bioequivalent Peptide Drugs Sales Model
Figure 52. Bioequivalent Peptide Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source